| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/17/2008 | EP1968935A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments |
| 09/17/2008 | EP1968576A1 Mif inhibitors |
| 09/17/2008 | EP1791825B1 Benzoyl-substituted serine amides |
| 09/17/2008 | EP1732892B1 Tetrahydrocarbazoles and derivatives |
| 09/17/2008 | EP1447400B1 Bicyclic compound |
| 09/17/2008 | CN101268062A 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the GABA-B-receptor |
| 09/17/2008 | CN101268048A Carbazole derivatives |
| 09/17/2008 | CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 09/17/2008 | CN101265227A Method for synthesizing 2,4-diamino[4'-(4-phenylacetylenylphthalimido)]diphenyl ether |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/17/2008 | CN100418625C Catalyst for synthesis of indole and its preparation method |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425575 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 09/16/2008 | US7425553 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 09/16/2008 | US7425550 Lactam glycogen phosphorylase inhibitors and method of use |
| 09/16/2008 | US7425401 Cyanine compounds, optical recording materials and optical recording media |
| 09/16/2008 | CA2180101C Process for the preparation of n-substituded glycine acids or glycine esters and use of said process for indigo synthesis |
| 09/12/2008 | WO2008109700A1 Ppar active compounds |
| 09/12/2008 | WO2008109333A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 09/12/2008 | WO2008108073A1 Immobilized cyclic imide catalyst and process for oxidation of organic compounds with the same |
| 09/12/2008 | WO2008107322A1 Indole, benzimidazole or benzotriazole derivatives including a piperidine or piperazine core as anti-neoplasic agents or cell proliferation inhibitors |
| 09/12/2008 | WO2008089453A3 Inhibitors of d-amino acid oxidase |
| 09/12/2008 | WO2008049997A3 Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 09/12/2008 | CA2679670A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 09/12/2008 | CA2679411A1 Ppar active compounds |
| 09/11/2008 | US20080221337 Reacting 3-(4-fluorophenyl)-1-isopropyl-1H-indole, 3,3-dimethoxypropionate, acetic acid and phosphorus oxychloride obtaining trans-3-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]acrylate |
| 09/11/2008 | US20080221322 Chemical process |
| 09/11/2008 | US20080221198 Novel Crystalline Forms of Antidiabetic Compounds |
| 09/11/2008 | US20080221197 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 09/11/2008 | US20080221196 Pharmaceutically active isoindoline derivatives |
| 09/11/2008 | US20080221195 N [(R)-1-Hydroxymethyl-2-(1H-indol-3-yl)-ethyl]-5-phenylethynyl-2-propoxy-benzamide; fertility control in men or in women, or for the prevention and/or treatment of osteoporosis; FSH antagonists |
| 09/11/2008 | US20080221194 Novel Potassium channel Blockers and Uses Thereof |
| 09/11/2008 | US20080221192 3-(4-Methyl-imidazol-1-yl)-N-{3-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indol-6-ylamino]-phenyl}-5-trifluoromethyl-benzamide; including benign and malignant proliferative disorders as well as diseases resulting from inappropriate activation of the immune and nervous systems |
| 09/11/2008 | US20080221160 Sulfonylated heterocycles useful for modulation of the progesterone receptor |
| 09/11/2008 | US20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents |
| 09/11/2008 | US20080220285 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices |
| 09/11/2008 | US20080220003 C5a Receptor Antagonists |
| 09/11/2008 | US20080217580 Organic Luminescent Element |
| 09/10/2008 | EP1967378A1 Optical recording medium and azacyanine dye |
| 09/10/2008 | EP1966233A1 An oxidation process for the preparation of n-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl-3-{n-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compounds |
| 09/10/2008 | EP1966135A2 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids |
| 09/10/2008 | EP1966134A1 Novel fused pyrrole derivatives |
| 09/10/2008 | EP1966118A1 Improved method for the production of ramipril |
| 09/10/2008 | EP1301474B1 Tyrosine derivatives as phosphatase inhibitors |
| 09/10/2008 | CN101263156A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 09/10/2008 | CN101263136A Benzimidazole derivatives as 5-HT6, 5-HT24 |
| 09/10/2008 | CN101263116A Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
| 09/10/2008 | CN101263115A Substituted indoles and use thereof |
| 09/10/2008 | CN101262866A Hemodynamics improving agent |
| 09/10/2008 | CN101260074A Non-substituted or tetra-substituted N-acyl-carbazoles compounds and synthesizing method thereof |
| 09/10/2008 | CN101260073A Quasi-peptides HIV-1 protease inhibitor, preparation method and use |
| 09/09/2008 | US7423161 Dithiocarboxylates, dithiocarbonates and trithiocarbonates in which the ester group is 1-substituted with a hydroxy, ether, amine or halo group, e.g., 1-(N-acetylamino)-2,2,2-trifluoroethyl]-O-ethyl dithiocarbonate and 1-ethoxythiocarbonylsulphanyl-2,2,2-trifluoro-ethyl ester of benzoic acid |
| 09/09/2008 | US7423155 (Meth)acrylates, e.g., 2-(p-(succinimidyl)sulfonyl)benzoyloxy)ethyl methacrylate; used for immobilization of amine-containing materials such as amino acidss, peptides, proteins, enzymes, immunoglobulins, DNA, RNA to substrate surfaces |
| 09/09/2008 | US7423058 Inhibitors of hepatitis C virus NS3 protease |
| 09/09/2008 | US7423056 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 09/09/2008 | US7423031 Compounds and compositions as protein kinase inhibitors |
| 09/04/2008 | WO2008106600A1 Bazedoxifene bis-phosphorates |
| 09/04/2008 | WO2008106334A2 Flame retarded styrenic polymer foams and foam precursors |
| 09/04/2008 | WO2008106125A2 Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists |
| 09/04/2008 | WO2008106059A1 Formulations for cathepsin k inhibitors |
| 09/04/2008 | WO2008105794A1 Process for the purification of carvedilol or its salts thereof |
| 09/04/2008 | WO2008105398A1 Cbp compound |
| 09/04/2008 | WO2008105349A1 Light-emitting element using spirofluorene derivative and electronic appliance |
| 09/04/2008 | WO2008104990A1 Amorphous carvedilol dihydrogen phosphate |
| 09/04/2008 | WO2008104597A2 Sulfonyltryptophanols |
| 09/04/2008 | WO2008104055A1 Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists |
| 09/04/2008 | WO2007137042A3 Process for preparing 7- (acryl0yl) -ind0les |
| 09/04/2008 | US20080214834 5,6-diethoxy-7-fluoro-3H-isoindol-1-ylamine; industrial scale production; hydrogenation; easy and safe reaction procedures and purification methods, high regioselectivity of reduction, and good yield |
| 09/04/2008 | US20080214833 Reacting 4-(oxiran-2-ylmethoxy)-9H-carbazole with 2-(2-methoxyphenoxy)ethylamine to make(+-) 1-(9H-carbazol-4-yloxy))-3-[2-(2-methoxyphenoxy)ethyl]amino-2-propanol; nonselective beta -adrenergic activity |
| 09/04/2008 | US20080214832 Process for making asenapine |
| 09/04/2008 | US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic |
| 09/04/2008 | US20080214647 {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid; thrombosis or fibrinolytic impairment is associated with formation of atherosclerotic plaques, venous and arterial thrombosis, myocardial ischemia, atrial fibrillation, deep vein thrombosis, coagulation syndromes |
| 09/04/2008 | US20080214646 Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety |
| 09/04/2008 | US20080214645 Administering 2-(1H-1-Indol-3-ylsulfanyl)benzyl]dimethyl amine; general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, specific phobias, social phobia and agoraphobia |
| 09/04/2008 | US20080214644 [2-(4-Fluoro-]. H-indol-3-ylsulfanyl)benzyl]dimethyl amine; depression, anxiety disorders including general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks |
| 09/04/2008 | US20080214597 Tricyclic Lactam Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 09/04/2008 | US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction |
| 09/04/2008 | US20080214538 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics |
| 09/04/2008 | US20080214524 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
| 09/04/2008 | US20080213217 (2-carbamoyl-5-chloro-1H-indol-3-yl)-[3-((E)-2-cyano-vinyl)-5-methyl-phenyl]-(S)-phosphinic acid methyl ester; Flaviviruses; bioavailability; pharmacokinetics |
| 09/04/2008 | CA2679175A1 Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists |
| 09/04/2008 | CA2678032A1 Bazedoxifene bis-phosphorates |
| 09/03/2008 | EP1964842A1 5H-THIENO [3,4-c]PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR |
| 09/03/2008 | EP1964836A2 A process for the preparation of perindopril erbumine in alpha crystalline form |
| 09/03/2008 | EP1964835A1 Derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer |
| 09/03/2008 | EP1964834A1 Sulphonyltryptophanols |
| 09/03/2008 | EP1963399A2 Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonist |
| 09/03/2008 | EP1963276A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 09/03/2008 | EP1963267A1 Process for the preparation of 6, 6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds and enantiomeric salts thereof |
| 09/03/2008 | EP1963266A1 Methods for purifying 2-aryl-3,3-bis(hydroxyaryl)phthalimidines |
| 09/03/2008 | EP1963265A1 Process for the preparation of perindopril and salts thereof |
| 09/03/2008 | EP1963264A2 New 3 -, 7-substituted indirubins and their applications |
| 09/03/2008 | CN101258194A A degradable polymer article |
| 09/03/2008 | CN101255130A Benzofluoranthene alkynes compounds and uses thereof |
| 09/03/2008 | CN101255129A Synthetic process of cyanine |
| 09/03/2008 | CN100415737C Indole derivatives useful for treatment of CNS disorders |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415715C Super-phthalocyanine compound with six isoindole structure subunits in laver oxazine cycle and its synthesis and use |
| 09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |